Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Processed Food Lawsuit Lawsuits are being pursued against the food industry over their manufacturing and advertising of ultra-processed foods, which have caused a generation of children to face an increased risk of developing childhood diabetes and other chronic illnesses.
Roundup Will Only Be Re-licensed in EU If Majority of Member States Agree, Commission Says July 18, 2017 Irvin Jackson Add Your Comments Amid continuing debate about the potential link between Roundup exposure and cancer within the scientific community, European regulators indicate that they will not reauthorize the use of the glyphosate-based weed killer unless a majority of member states agree. European Health and Food Safety Commissioner Vytenis Andriukaitis made a statement on Monday, at a meeting of European Union (EU) agricultural officials, indicating that the European Commission will not re-authorize the use of glyphosate, the active ingredient in Roundup, if most member states object, even though his agency believes the herbicide is safe. The statement comes amid conflicting scientific opinions about the risk of non-Hodkins lymphoma and other cancers from Roundup, and questions about the degree of influence Monsanto has had over prior decisions made by regulatory agencies in the U.S. and Europe. ROUNDUP LAWSUITS Were you or a loved one exposed to RoundUp? Exposure to RoundUp has been linked to an increased risk of developing Non-Hodgkin’s Lymphoma and other cancers. RoundUp cancer lawsuits are being actively investigated. Learn More SEE IF YOU QUALIFY FOR COMPENSATION ROUNDUP LAWSUITS Were you or a loved one exposed to RoundUp? Exposure to RoundUp has been linked to an increased risk of developing Non-Hodgkin’s Lymphoma and other cancers. RoundUp cancer lawsuits are being actively investigated. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Worldwide debate began about the safety of Roundup after the World Health Organization’s International Agency for Research on Cancer (IARC) classified glyphosate as a probable human carcinogen in 2015. Although Monsanto has continued to defend the safety of Roundup, calling the IARC findings junk science, experts worldwide have voiced concerns and recent evidence uncovered during on-going Roundup litigation in the United States suggests that the manufacturer has manipulated data and that regulators may have relied too heavily on industry-sponsored research. The re-authorization of glyphosate in Europe is problematic, even after the statement by Andriukaitis. The original license expired in June 2016, but so far, in previous efforts, the EU has been unable to reach a consensus. What’s more, there has never been a majority of member states voting for or against glyphosate reapproval because France and Germany have abstained from voting. This resulted in the chemical getting an 18-month extension, which expires in December 2017. The European Commission has proposed giving Roundup and other glyphosate-based herbicides a 10-year extension. It came to this conclusion after the European Chemical Agency (ECHA) determined that glyphosate should not be considered a carcinogen. If the member states reject that proposal, glyphosate use would be effectively banned throughout Europe. However, the European Commission’s decisions on glyphosate are now coming under scrutiny. Earlier this month, a group of European Parliament members sent a letter to the U.S. judge presiding over the Roundup litigation, asking to be provided copies of the so-called “Monsanto Papers,” which link the company to the “ghostwriting” of studies about the safety of Roundup and it’s active ingredient, glyphosate. They are also asking for documents suggesting that Jess Rowlands, of the U.S. Environmental Protection Agency (EPA), worked with the company to hide evidence of links between glyphosate and cancer. The EU members’ letter came in response to information disclosed during the discovery process in the Roundup litigation, including documents that suggested a former EPA official, Jess Rowland, reassured Monsanto that there would be no pesticide review for glyphosate. Rowland reportedly even wrote that he “should get a medal” for protecting the company’s product. The documents also indicated that Monsanto had ghostwritten academic research articles indicating Roundup was safe and then paid other researchers to put their name on the bogus studies. The letter from members of the European Parliament also outline concerns about the independence of their own regulators, indicating that Monsanto and the pesticide industry had advance access to a safety assessment of glyphosate conducted by the European Food Safety Authority (EFSA) in 2015, and even were able to edit the documents at the last minute. As U.S. and foreign regulators continue to debate the safety of the weedkiller, hundreds of Roundup lawsuits are proceeding through the American court system, involving allegations that farmers, landscapers and other individuals regularly exposed to glyphosate developed non-Hodgkins lymphoma or other cancers. Plaintiffs maintain that they may have avoided the diagnosis if Monsanto had provided warnings and instructions about appropriate safety precautions. Tags: Cancer, Glyphosate, Herbicide, Monsanto, Non-Hodgkins Lymphoma, Roundup, Weed Killer More Roundup Lawsuit Stories Bayer’s Roundup Settlement Plan May Result in Monsanto Bankruptcy Filing: Report May 19, 2025 Georgia Lawmakers Agree To Shield Bayer From Roundup Cancer Lawsuits May 15, 2025 Roundup Exposure May Increase Infertility, Endometriosis Risks: Study May 1, 2025 0 Comments Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermEmailThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES 6 Bard PowerPort Lawsuits Selected for Bellwether Trials in Federal MDL (Posted: today) A federal judge has identified the six Bard PowerPort lawsuits that will serve as the first bellwether trials, to test allegations that the port catheters were defectively designed. MORE ABOUT: BARD POWERPORT LAWSUITCourt Indicates Bard PowerPort MDL Bellwether Lawsuits Should Include 3 Infection, 2 Thrombosis and 1 Fracture Case (05/06/2025)Lawyers Proposed 11 Bard Implantable Port Catheter Lawsuits as Bellwether Trial Candidates (04/30/2025)Bard PowerPICC Intravascular Catheter Leaks Linked to Reports of Serious Injuries: FDA (04/21/2025) MDL Judge Orders Paraquat Lawsuit Settlement Update By June 11, 2025 (Posted: 3 days ago) A federal judge has agreed to stay all case-specific discovery deadlines in Paraquat lawsuits, while the parties work to hammer out a settlement agreement to resolve thousands of claims. MORE ABOUT: PARAQUAT PARKINSON’S DISEASE LAWSUITSParaquat Settlement Reached for Parkinson’s Disease Lawsuits Filed in MDL (04/16/2025)Appeals Court Urged To Reinstate Paraquat Lawsuits Previously Set for Bellwether Trials (02/14/2025)Paraquat Lawsuits Over Parkinson’s Disease Risk Set for Trial in October 2025, April 2026 (01/29/2025) Court Outlines Requirements for Depo-Provera Lawsuit Proof of Use, Type of Meningioma Tumor (Posted: 4 days ago) As new Depo-Provera lawsuits continue to be filed, the judge presiding over the litigation has established key criteria for establishing proof of Depo-Provera use and medical documentation confirming a meningioma diagnosis. MORE ABOUT: DEPO-PROVERA LAWSUITDepo Shot Lawsuit Filed Over Serious Brain Tumor Injuries (05/07/2025)Lawsuit Alleges Depo-Provera Migraines, Headaches Led to Meningioma Brain Tumor Diagnosis (05/01/2025)Depo-Provera Hearing Loss Lawsuit Filed Over Brain Tumor Side Effects (04/22/2025)
6 Bard PowerPort Lawsuits Selected for Bellwether Trials in Federal MDL (Posted: today) A federal judge has identified the six Bard PowerPort lawsuits that will serve as the first bellwether trials, to test allegations that the port catheters were defectively designed. MORE ABOUT: BARD POWERPORT LAWSUITCourt Indicates Bard PowerPort MDL Bellwether Lawsuits Should Include 3 Infection, 2 Thrombosis and 1 Fracture Case (05/06/2025)Lawyers Proposed 11 Bard Implantable Port Catheter Lawsuits as Bellwether Trial Candidates (04/30/2025)Bard PowerPICC Intravascular Catheter Leaks Linked to Reports of Serious Injuries: FDA (04/21/2025)
MDL Judge Orders Paraquat Lawsuit Settlement Update By June 11, 2025 (Posted: 3 days ago) A federal judge has agreed to stay all case-specific discovery deadlines in Paraquat lawsuits, while the parties work to hammer out a settlement agreement to resolve thousands of claims. MORE ABOUT: PARAQUAT PARKINSON’S DISEASE LAWSUITSParaquat Settlement Reached for Parkinson’s Disease Lawsuits Filed in MDL (04/16/2025)Appeals Court Urged To Reinstate Paraquat Lawsuits Previously Set for Bellwether Trials (02/14/2025)Paraquat Lawsuits Over Parkinson’s Disease Risk Set for Trial in October 2025, April 2026 (01/29/2025)
Court Outlines Requirements for Depo-Provera Lawsuit Proof of Use, Type of Meningioma Tumor (Posted: 4 days ago) As new Depo-Provera lawsuits continue to be filed, the judge presiding over the litigation has established key criteria for establishing proof of Depo-Provera use and medical documentation confirming a meningioma diagnosis. MORE ABOUT: DEPO-PROVERA LAWSUITDepo Shot Lawsuit Filed Over Serious Brain Tumor Injuries (05/07/2025)Lawsuit Alleges Depo-Provera Migraines, Headaches Led to Meningioma Brain Tumor Diagnosis (05/01/2025)Depo-Provera Hearing Loss Lawsuit Filed Over Brain Tumor Side Effects (04/22/2025)